Ilan Bruchim

3.8k total citations
4 papers, 8 citations indexed

About

Ilan Bruchim is a scholar working on Reproductive Medicine, Oncology and Sociology and Political Science. According to data from OpenAlex, Ilan Bruchim has authored 4 papers receiving a total of 8 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Reproductive Medicine, 2 papers in Oncology and 1 paper in Sociology and Political Science. Recurrent topics in Ilan Bruchim's work include Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Ilan Bruchim is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Ilan Bruchim collaborates with scholars based in Canada, Israel and Spain. Ilan Bruchim's co-authors include Luca Mariani, Marcia Craib, Michelle Wilson, Toon Van Gorp, Bhavana Pothuri, P Sismondi, Keiichi Fujiwara, Limor Helpman, Vicky Makker and Flora Zagouri and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and International Journal of Gynecological Cancer.

In The Last Decade

Ilan Bruchim

3 papers receiving 7 citations

Peers

Ilan Bruchim

RM

ONCOL

PRM

OG

GENET

Hailei Zhang United Kingdom

Stephanie Chung United States

Chloe A Logue United Kingdom

E. C. Graham United States

N Thejeswar India

C. Gnanachandran United Kingdom

Valeriya Saevets United States

Chun Sen Lim Malaysia

R. Cesaraccio Italy

Audrey J. Gaskins United States

Hailei Zhang United Kingdom

Ilan Bruchim

4 ×0.6

RM

6 ×1.2

ONCOL

2 ×1.0

PRM

0 ×0.0

OG

2 ×1.0

GENET

Citations per year, relative to Ilan Bruchim Ilan Bruchim (= 1×) peers Hailei Zhang

Countries citing papers authored by Ilan Bruchim

Since Specialization

Citations

This map shows the geographic impact of Ilan Bruchim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Bruchim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Bruchim more than expected).

Fields of papers citing papers by Ilan Bruchim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Bruchim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Bruchim. The network helps show where Ilan Bruchim may publish in the future.

Co-authorship network of co-authors of Ilan Bruchim

This figure shows the co-authorship network connecting the top 25 collaborators of Ilan Bruchim. A scholar is included among the top collaborators of Ilan Bruchim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilan Bruchim. Ilan Bruchim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Valabrega, Giorgio, Ignace Vergote, Debra L. Richardson, et al.. (2025). Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study. International Journal of Gynecological Cancer. 35(2). 100081–100081. 1 indexed citations

2.

O’Malley, David M., Bradley Monk, Myong Cheol Lim, et al.. (2024). Final safety results from ATHENA–MONO (GOG-3020/ENGOT-ov45), a randomized, placebo-controlled, double-blind, phase 3 trial evaluating rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5554–5554. 4 indexed citations

3.

Kadan, Yfat, et al.. (2022). Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer. Gynecologic Oncology. 167(2). 256–260. 3 indexed citations

4.

Schmidt, M., P Sismondi, Ilan Bruchim, et al.. (2006). Gesellschaftsnachrichten. Gyn�kologisch-geburtshilfliche Rundschau. 46(4). 218–219.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact